Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 39, 2009 - Issue 4
719
Views
29
CrossRef citations to date
0
Altmetric
Research Article

Inhibition of human glutathione S-transferases by curcumin and analogues

, , , &
Pages 302-311 | Received 15 Oct 2008, Accepted 18 Dec 2008, Published online: 01 Apr 2009

References

  • Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. (2007). Bioavailability of curcumin: Problems and promises. Mol Pharm 4:807–818.
  • Appiah-Opong R, Commandeur JNM, van Vugt-Lussenburg B, Vermeulen NPE. (2007a). Inhibition of human recombinant cytochrome P450s by curcumin and curcumin decomposition products. Toxicology 235:83–91.
  • Appiah-Opong R, de Esch I, Commandeur JNM, Andarini M, Vermeulen NPE. (2007b). Structure–activity relationship for the inhibition of recombinant human cytochrome P450 mediated metabolism by curcumin analogues. Eur J Med Chem 43:1621–1631.
  • Awasthi YC, Sharma R, Singhal SS. (1994). Human glutathione S-transferases. Int J Biochem 26:295–308.
  • Bradford MM. (1976). A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein–dye binding. Anal Biochem 72:248–254.
  • Burg D, Filippov DV, Hermanns R, van der Marel GA, Van Boom JH, Mulder GJ. (2002). Peptidomimetic glutathione analogues as novel gamma GT stable inhibitors. Bioorg Med Chem 10:195–205.
  • Burg D, Mulder GJ. (2002). Glutathione conjugates and their synthetic derivatives as inhibitors of glutathione-dependent enzymes involved in cancer and drug resistance. Drug Metab Rev 34:821–863.
  • Chandra RK, Bentz BG, Haines GK, Robinson AM, Radosevich JA. (2002). Expression of glutathione S-transferase Pi in benign mucosa, Barrett’s metaplasia, and adenocarcinoma of the esophagus. Head Neck 24:575–581.
  • Chen A, Xu J, Johnson AC. (2006). Curcumin inhibits human colon cancer cell growth by suppressing gene expression of epidermal growth factor receptor through reducing the activity of the transcription factor Egr-1. Oncogene 25:278–287.
  • Cheng AL, Hsu CH. Lin JK, Hsu MM, Ho YF, Shen TS, Ko JY, Lin JT, Lin BR, Ming-Shiang W, Yu HS, Jee SH, Chen GS, Chen TM, Chen CA, Lai MK, Pu YS, Pan MH, Wang JY, Tsai CC, Hsieh CY. (2001). Phase I clinical trial of curcumin, a chemo preventive agent, in patients with high-risk or premalignant lesions. Anticancer Res 21(4B):2895–2900.
  • Cole GM, Morihara T, Lim GP, Yang F, Begum A, Frautschy SA. (2004). NSAID and antioxidant prevention of Alzheimer’s disease: lessons from in vitro and animal models. Annals NY Acad Sci 1035:68–84.
  • Commandeur JN, Stijntjes GJ, Vermeulen NP. (1995). Enzymes and transport systems involved in the formation and disposition of glutathione S-conjugates. Role in bioactivation and detoxication mechanisms of xenobiotics. Pharmacol Rev 47:271–330.
  • Depeille P, Cuq P, Passagne, I, Evrard A, Vian L. (2005). Combined effects of GSTP1 and MRP1 in melanoma drug resistance. Br J Cancer 93:216–223.
  • Eaton DL, Bammler TK. (1999). Concise review of glutathione S-transferases and their significance to toxicology. Toxicol Sci 49:156–164.
  • Ericksson L, Jaworska J, Worth AP, Cronin MT, McDowell RM, Gramatica P. (2003). Methods for reliability and uncertainty assessment and for applicability evaluations of classification- and regression-based QSARs. Environ Hlth Perspect 111:1361–1375.
  • Frova C (2006). Glutathione transferases in the genomics era: new insights and perspectives. Biomol Eng 23:149–169.
  • Hayeshi R, Mutingwende I, Mavengere W, Masiyanise V, Mukanganyama S. (2007). Inhibition of human glutathione S-transferases activity by plant polyphenolic compounds ellagic acid and curcumin. Food Chem Toxicol 45:286–295.
  • Lin L, Shi Q, Nyarko AK, Bastow KF, Wu CC, Su CY, Shih CC, Lee KH. (2006). Antitumor agents. 250. Design and synthesis of new curcumin analogues as potential anti-prostate cancer agents. J Med Chem 49:3963–3972.
  • Morrow CS, Simitherman PK, Townsend AJ. (2000). Role of multidrug-resistance protein 2 in glutathione S-transferase P1-1-mediated resistance to 4-nitroquinoline 1-oxide toxicities in HepG2 cells. Mol Carcinog 29:170–178.
  • Moscow JA, Fairchild CR, Madden MJ, Ransom DT, Wieand HS, O’Brien EE, Poplack DG, Cossman J, Myers CE, Cowman KH. (1989). Expression of anionic glutathione S-transferase and P-glycoprotein genes in human tissues and tumors. Cancer Res 49:1422–1428.
  • Mukanganyama S, Widersten M, Naik YS, Mannervik B, Hasler JA. (2002). Inhibition of glutathione S-transferases by antimalarial drugs possible implications for circumventing anticancer drug resistance. Int J Cancer 97:700–705.
  • Nonn L, Doung D, Peehl DM. (2007). Chemopreventive anti-inflammatory activities of curcumin and other phytochemicals mediated by MAP kinase phosphatase-5 in prostate cells. Carcinogenesis 28:1188–1196.
  • Oetari S, Sudibyo M, Commandeur JNM, Samboedi R, Vermeulen NPE. (1996). Effects of curcumin on cytochrome P450 and glutathione S-transferase activities in rat liver. Biochem Pharmacol 51:39–45.
  • Piipari R, Nurminen T, Savela K, Hirvonen A, Mantyla T, Anttila S. (2003). Glutathione S-transferases and aromatic DNA adducts in smokers bronchioaveolar macrophages. Lung Cancer 39:265–272.
  • Rooseboom M, Vermeulen, NPE, Groot EJ, Commandeur JNM. (2002). Tissue distribution of cytosolic beta-elimination reactions of selenocysteine Se-conjugates in rat and human. Chem Biol Interact 140:243–264.
  • Sardjiman S, Reksohadiprodjo M, Hakim L, Van der Goot H, Timmerman H. (1997). 1,5-Diphenyl-1,4-pentadiene-3-ones and cyclic analogues as antioxidative agents. Synthesis and structure–activity relationship. Eur J Med Chem 32:625–636.
  • Shahapurkar S, Pandya T, Kawathekar N, Chaturvedi SC. (2004). Quantitative structure activity relationship studies of diaryl furanones as selective COX-2 inhibitors. Eur J Med Chem 39:899–904.
  • Sharma RA, Euden SA, Platton SL, Cooke DN, Shafayat A, Hewitt HR, Marczylo TH, Morgan B, Hemingway D, Plummer SM, Pirmohamed M, Gescher AJ, Steward WP. (2004). Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance. Clin Cancer Res 10:6847–6854.
  • Sluis-Cremer N, Naidoo N, Dirr H. (1996). Class-pi glutathione is unable to regain its native conformation after oxidative inactivation by hydrogen peroxide. Eur J Biochem 242:301–307.
  • Townsend DM, Tew KD. (2003). The role of glutathione-S-transferase in anti-cancer drug resistance. Oncology 22:7369–7375.
  • Vajragupta O, Boonchoong P, Morris GM, Olson AJ. (2005). Active site binding modes of curcumin in HIV-1 protease and integrase. Bioorg Med Chem Lett 15:3364–3368.
  • Van Bladeren PJ. (2000). Glutathione conjugation as a bioactivation reaction. Chem Biol Interact 129:61–79.
  • Van Bladeren PJ, Van Ommen B. (1991). The inhibition of glutathione S-transferases: mechanisms, toxic consequences and therapeutic benefits. Pharmacol Ther 51:35–46.
  • Van Haaften RIM, Haenen GRMM, Van Bladeren PJ, Bogaards JJP, Evelo CTA, Bast A. (2003). Inhibition of glutathione S-transferase isoenzymes by RRR-α-tocopherol. Toxicol in Vitro 17:245–251.
  • Van Iersel ML, Ploemen JP, Lo Bello M, Federici G, Van Bladeren PJ. (1997). Interactions of alpha, beta-unsaturated aldehydes and ketones with human glutathione S-transferase P1-1. Chem Biol Interact 108:67–78.
  • Youssef KM, El-Sherbeny MA, El-Shafie FS, Farag HA, Al-Deeb OA, Awadalla SAA. (2004). Synthesis of curcumin analogues as potential antioxidant, cancer preventive agents. Arch Pharm (Weinheim) 337:42–54.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.